Concepedia

Publication | Open Access

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

DOIFull Paper Access

58

Citations

45

References

2023

Year

Amanda J. Compadre, Lillian N. van Biljon, Mark C. Valentine, Alba Llop‐Guevara, Emily Graham, Bisiayo Fashemi, Andrea Herencia-Ropero, Emilee N. Kotnik, Isaac Cooper, Shariska P. Harrington,
Clinical Cancer Research

Abstract

RAD51 foci are a robust marker of platinum chemotherapy response and survival in ovarian cancer. The utility of RAD51 foci as a predictive biomarker for HGSOC should be tested in clinical trials.

References

YearCitations

Page 1